Travel size Afrin nasal spray lacks required child-resistant packaging
Travel Size Afrin Original Nasal Spray 6 mL bottles are recalled because the packaging does not meet Poison Prevention Packaging Act requirements for imidazolines.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Packaging that fails the mandatory child-resistant requirement for an imidazoline creates a poisoning risk of harm; no incidents are reported, capping it at High.
Plain-English summary
Travel Size Afrin Original Nasal Spray 6 mL bottles are being recalled. Affected lot numbers are 230361, 240822, 241198, 250066, 250152, 250646 and 250831. About 786,100 units are affected.
The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labelling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The packaging does not meet those requirements. No incidents or injuries have been reported.
The sprays were sold at retailers including convenience stores and travel hubs such as airports from September 2024 to April 2026 for about $7 to $9.
Consumers should immediately secure the recalled bottles out of sight and reach of children and go to the webform posted at www.livewell.bayer.com/afrin-original-spray-recall for the remedy.
The recalled product
- Product
- Travel Size Afrin® Original Nasal Spray 6 mL Bottles
- Manufacturer
- Bayer HealthCare LLC, of Whippany, New Jersey
- Category
- Consumer Product — Nasal spray
- Affected units
- 786,100
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · child resistant packaging
See all →- HighMedPride baby oil lacks the required child-resistant packaging
CPSC · 2026-06-25
- High
- High
- High
- High